Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Maresca

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cancers|January 20, 2021
Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic TargetMargherita Cortini, Andrea Armirotti, Marta Columbaro, et al.
Bioscience Reports|May 5, 2007
Mitochondrial optic neuropathies: how two genomes may kill the same cell type?Valerio Carelli, Chiara La Morgia, Luisa Iommarini, et al.
Human Molecular Genetics|September 28, 2015
Targeting estrogen receptor β as preventive therapeutic strategy for Leber's hereditary optic neuropathyAnnalinda Pisano, Carmela Preziuso, Luisa Iommarini, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
Brain : a Journal of Neurology|February 8, 2013
Idebenone treatment in patients with OPA1-mutant dominant optic atrophyPiero Barboni, Maria Lucia Valentino, Chiara La Morgia, et al.
Journal of Lipid Research|May 19, 2024
Lipidomics reveals the reshaping of the mitochondrial phospholipid profile in cells lacking OPA1 and mitofusinsAndrea Castellaneta, Ilario Losito, Vito Porcelli, et al.
Neurogenetics|March 1, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, M Lucia Valentino, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Neurogenetics|December 4, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, Maria Lucia Valentino, et al.
Journal of Medical Genetics|September 21, 2023
Recessive <i>MECR</i> pathogenic variants cause an LHON-like optic neuropathyClaudio Fiorini, Andrea Degiorgi, Maria Lucia Cascavilla, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancers|January 20, 2021
Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic TargetMargherita Cortini, Andrea Armirotti, Marta Columbaro, et al.
Bioscience Reports|May 5, 2007
Mitochondrial optic neuropathies: how two genomes may kill the same cell type?Valerio Carelli, Chiara La Morgia, Luisa Iommarini, et al.
Human Molecular Genetics|September 28, 2015
Targeting estrogen receptor β as preventive therapeutic strategy for Leber's hereditary optic neuropathyAnnalinda Pisano, Carmela Preziuso, Luisa Iommarini, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
Brain : a Journal of Neurology|February 8, 2013
Idebenone treatment in patients with OPA1-mutant dominant optic atrophyPiero Barboni, Maria Lucia Valentino, Chiara La Morgia, et al.
Journal of Lipid Research|May 19, 2024
Lipidomics reveals the reshaping of the mitochondrial phospholipid profile in cells lacking OPA1 and mitofusinsAndrea Castellaneta, Ilario Losito, Vito Porcelli, et al.
Neurogenetics|March 1, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, M Lucia Valentino, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Neurogenetics|December 4, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, Maria Lucia Valentino, et al.
Journal of Medical Genetics|September 21, 2023
Recessive <i>MECR</i> pathogenic variants cause an LHON-like optic neuropathyClaudio Fiorini, Andrea Degiorgi, Maria Lucia Cascavilla, et al.
Pageof 7